InfuSystem Holdings postponed the release of its third-quarter 2026 results, which had been scheduled for Nov. 3, saying it needs more time to complete quarter-end reporting. The company is also reviewing how to account for costs related to its new enterprise resource planning (ERP) system.
The review could affect when some costs are recognized in the company’s financial statements. InfuSystem has not announced a revised date for the results or the related conference call; it expects to do so as soon as practicable.
Key details
- InfuSystem is evaluating, with its Audit Committee and independent auditor, whether certain ERP implementation costs should have been capitalized and amortized over the remaining three-year term of the software subscription agreement, rather than expensed as incurred.
- The ERP system went live on March 1, 2026. From July 1, 2024, through its launch, InfuSystem expensed $4.2 million in implementation costs and reported them separately in its earnings releases.
- The company has not reached a decision on the accounting treatment. Any adjustment would be non-cash and would not affect revenue or cash balances.
- The third-quarter results and conference call have both been postponed. A new date has not yet been set.
Plain-English implications
If InfuSystem changes the accounting treatment, some implementation costs could be recognized over time instead of being recorded as expenses when incurred. That would change the timing of reported expenses, but the company says any adjustment would not change its cash balances or revenue.